Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22984437 | 0.75 | ACHE (0.35) | — | |
| SCHEMBL22984486 | 0.72 | CA12 (0.33) | RAPGEF4 | |
| SCHEMBL22984484 | 0.70 | ALDH1A1 (0.38) | — | |
| SCHEMBL19968364 | 0.67 | CES2 (0.33) | RAPGEF4 | |
| SCHEMBL1042989 | 0.65 | CES2 (0.32) | — | |
| SCHEMBL1041954 | 0.65 | CES2 (0.32) | — | |
| SCHEMBL2541480 | 0.65 | RAPGEF4 (0.48) | RAPGEF4 | |
| SCHEMBL8035545 | 0.65 | CES2 (0.32) | — | |
| SCHEMBL22984477 | 0.65 | RAPGEF4 (0.33) | RAPGEF4 | |
| SCHEMBL19968258 | 0.65 | ERN1 (0.31) | RAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919031-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919031-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | RAPGEF4 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.